2,654
edits
Honest Broker: Difference between revisions
Jump to navigation
Jump to search
no edit summary
No edit summary |
No edit summary |
||
| Line 63: | Line 63: | ||
:*Introduce the research study; | :*Introduce the research study; | ||
:*Ascertain their interest in study participation; and | :*Ascertain their interest in study participation; and | ||
:*Obtain written authorization to share their interest in study participation with the investigators and allow patients to be contacted. The honest broker would not directly contact the patient. | :*Obtain written authorization to share their interest in study participation with the investigators and allow patients to be contacted by researcher. The honest broker would not directly contact the patient. | ||
:*After secondary review by the Associate Vice Chancellor for Clinical Research, an honest broker may provide the research investigator with a list of potentially eligible patients who have agreed to be contacted for research studies they are eligible for based on their election on the Conditions of Treatment form or consistent with the Human Research Protection Program Policy #3.4 “Use of Protected Health Information in Research and Registries” for further information. | :*After secondary review by the Associate Vice Chancellor for Clinical Research, an honest broker may provide the research investigator with a list of potentially eligible patients who have agreed to be contacted for research studies they are eligible for based on their election on the Conditions of Treatment form or consistent with the Human Research Protection Program Policy #3.4 “Use of Protected Health Information in Research and Registries” for further information. | ||
*Honest broker Data Requests: Individuals requesting PHI or de-identified data shall complete: | *Honest broker Data Requests: Individuals requesting PHI or de-identified data shall complete: | ||